A substantial component of the success story of Medicon Valley is the global outlook of key stakeholders. Fortunately, the Danish-Swedish Medicon Valley life science cluster is international by nature. But how do we use this to our advance and what is needed if we are to use the combination of Danish and Swedish life science expertise as the stepping stone for the ambitions to position the Nordics as a global life science innovation hub?
Only a region working actively to become an attractive destination for life science companies, investments, talents and academic excellence can aspire to become a true world class life science cluster.
To discuss how to ensure the competitiveness of our region in a globalized world, Medicon Valley Alliance has the pleasure of inviting you to an afternoon with inspirational regional, national and international speakers.
Date: Monday November 2, 2020
Time: 12.30 – 17.00
On-line: You can access the live streaming here
This year we will be offering our Annual Meeting for online participation!
Recording of MVA’s Annual Meeting 2020
PROGRAM
Click here for a mobile-friendly program.
| 12:30 – 12:35 | Welcome Petter Hartman, CEO, Medicon Valley Alliance |
| 12:35 – 12:50 | State of Medicon Valley – Life science in Greater Copenhagen Petter Hartman, CEO, Medicon Valley Alliance View Slides Petter Hartman |
| 12:50 – 14:00 | Framework conditions for life science and innovation |
| 12:50 – 13:15 | Mobilizing the Öresund Region for Innovation: The Case of Life Sciences Christian Ketels, Global expert on economic competitiveness and clusters View slides Christian Ketels |
| 13:15 – 13:30 | The need to change the healthcare system for the benefits of patients and society: Merck’s perspective Enrique Álvarez Fernández, Managing Director and General Manager, Merck Group View slides Enrique Álvarez Fernández |
| 13:30 – 13:45 | Digital transformation for commercial life science – what are the learnings for a post COVID-19 world? Berkeley Vincent, Managing Director Nordic Cluster, Janssen Europe, Middle East & Africa View slides Berkeley Vincent |
| 13:45 – 14:15 | Coffee break |
| 14:15 – 15:20 | Investment focus |
| 14:15 – 14:30 | Funding opportunities for innovation in life science: New partnerships in the eco system Anne-Marie Levy Rasmussen, CEO, Innovation Fund Denmark View slides Anne-Marie Levy |
| 14:30 – 14:45 | We need system innovation in life science and society as a whole. But how? Darja Isaksson, Director General, Vinnova View slides Darja Isaksson |
| 14:45 – 15:00 | Eir Ventures: Regional investment with an international perspective Amanda Hayward, Partner, Eir Ventures |
| 15:00 – 15:20 | Lounge discussion |
| 15:20 – 15:50 | Coffee break |
| 15:50 – 17:00 | Innovation during COVID-19 |
| 15:50 – 16:05 | Necessity is the mother of invention – how an unprecedented global need facilitated new constellations within biotech Martina Kvist Reimer, Executive Vice President, Red Glead Discovery View slides Martina Kvist Reimer |
| 16:05 – 16:20 | A versatile vaccine platform – antigen display on the surface of the capsid like particles Morten Agertoug Nielsen, Associate Professor, CMP, Dept. of Immunology and Microbiology, University of Copenhagen |
| 16:20 – 16:35 | The potential of Stem cells in treating covid-19 ARDS Evy Lundgren-Åkerlund, CEO, Xintela AB View slides Evy Lundgren-Åkerlund |
| 16:35 – 16:50 | Mapping the adaptive immune response to SARS-CoV2 Stephan Thorgrimsen, CEO, Immunitrack View slides StephanThorgrimsen |
| 16:50 – 17:00 | Summary and conclusions Søren Bregenholt, Chairman of the board, Medicon Valley Alliance, CEO, Macrophage Pharma |
SPEAKERS
The list of speakers will be updated on an ongoing basis.
 |
 |
 |
| Christian Ketels Global expert on economic competitiveness and clusters |
Enrique Álvarez Fernández Managing Director and General Manager Merck Group |
Berkeley Vincent Managing Director Nordic Cluster Janssen Europe, Middle East & Africa |
 |
 |
 |
| Anne-Marie Levy Rasmussen CEO Innovation Fund Denmark |
Darja Isaksson Director General Vinnova |
Amanda Hayward Partner Eir Ventures |
 |
 |
 |
| Martina Kvist Reimer Executive Vice President Red Glead Discovery |
Morten Agertoug Nielsen Associate Professor Dept. of Immunology and Microbiology University of Copenhagen |
Evy Lundgren-Åkerlund CEO Xintela AB |
 |
 |
|
| Stephan Thorgrimsen CEO Immunitrack |
Petter Hartman CEO Medicon Valley Alliance |
|
|
MODERATORS |
||
 |
 |
|
| Sarah Lidé Senior Strategy and Project Manager Medicon Valley Alliance |
Søren Bregenholt Chairman of the board Medicon Valley Alliance CEO, Macrophage Pharma |
MVA’s Annual meeting is the annual flagship event of Medicon Valley Alliance. We invite prominent regional, national and international speakers to address key topics such as life science innovation, commercialization of R&D, public private partnerships, talent attraction and other issues of importance for the realization of our vision for the Medicon Valley cluster. Last year’s annual meeting titled “Ambitions and Visions”, was attended by 250+ prominent regional life science stakeholders.
SPONSORS
 |
 |
Do you want to become a sponsor of the Annual Meeting? Contact David Zepernick, dz@mva.org or (+45) 24 98 16 68.
PARTICIPATION
Participation is free of charge for members of MVA and members of the press (late cancellation* /no-show fee DKK 500 excl. VAT).
Non-members can access the event by invitation only. Please contact us at nm@mva.org.
Registration ends on October 31st, 2020.